Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status:
Completed
Trial end date:
2020-05-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and
tolerability in pediatric participants with moderately to severely active UC or CD.